An Advanced Therapy Medicinal Product is a medicinal product based on genes, cells, or tissues, regulated under a specific framework by the EMA. ATMPs include gene therapy medicinal products (GTMPs), somatic cell therapy medicinal products (sCTMPs), and tissue-engineered products (TEPs), and are subject to centralized marketing authorization in the European Union.
